AbCellera Reports Q3 2026 Financial Results: Revenue at $10. ...

GuruFocus | Nov 9, 2026 4:50 PM EST

Clinical progress and a $200 million capital raise reshape the balance sheet as revenue lands below analyst estimates Related Stocks: ABCL ,